A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Serruys, Patrick W, Prof ; Chevalier, Bernard, MD ; Dudek, Dariusz, MD ; Cequier, Angel, MD ; Carrié, Didier, MD ; Iniguez, Andres, MD ; Dominici, Marcello, MD ; van der Schaaf, René J, MD ; Haude, Michael, MD ; Wasungu, Luc, PhD ; Veldhof, Susan, RN ; Peng, Lei, MSc ; Staehr, Peter, MD ; Grundeken, Maik J, MD ; Ishibashi, Yuki, MD ; Garcia-Garcia, Hector M, MD ; Onuma, Yoshinobu, MD

The Lancet (British edition), 2015-01, Vol.385 (9962), p.43-54 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível